Update of the treatment of nosocomial pneumonia in the ICU
| العنوان: | Update of the treatment of nosocomial pneumonia in the ICU |
|---|---|
| المؤلفون: | Alejandro Rodriguez, Marcio Borges, J. Veganzones, Ignacio Martin-Loeches, Cruz Soriano, Pablo Vidal-Cortés, Emili Díaz, Mercedes Nieto, Rafael Zaragoza, Paula Ramirez, Francisco Xavier Nuvials, Emilio Maseda, Gerardo Aguilar, Ricard Ferrer |
| المصدر: | Critical Care Critical Care, Vol 24, Iss 1, Pp 1-13 (2020) CRITICAL CARE r-FISABIO. Repositorio Institucional de Producción Científica instname r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe r-FISABIO: Repositorio Institucional de Producción Científica Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) |
| بيانات النشر: | BioMed Central, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Nosocomial pneumonia, Resuscitation, Surviving Sepsis Campaign, medicine.medical_treatment, Antibiotics, humanos, Review, Critical Care and Intensive Care Medicine, 0302 clinical medicine, Risk Factors, guías como asunto, Epidemiology, 030212 general & internal medicine, 0303 health sciences, Ceftolozane-tazobactam, lcsh:Medical emergencies. Critical care. Intensive care. First aid, Pneumonia, Ventilator-Associated, Anti-Bacterial Agents, Intensive Care Units, PCR, Pseudomonas aeruginosa, antibacterianos, medicine.drug, medicine.medical_specialty, medicine.drug_class, Critical Illness, unidades de cuidados intensivos, enfermedad crítica, Guidelines as Topic, 03 medical and health sciences, Antibiotic resistance, medicine, factores de riesgo, Humans, Intensive care medicine, Mechanical ventilation, 030306 microbiology, business.industry, Ceftazidime-avibactam, Healthcare-Associated Pneumonia, neumonía, lcsh:RC86-88.9, Pneumonia, HAP, Ceftazidime/avibactam, medicine.disease, KPC, VAP, business |
| الوصف: | In accordance with the recommendations of, amongst others, the Surviving Sepsis Campaign and the recently published European treatment guidelines for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), in the event of a patient with such infections, empirical antibiotic treatment must be appropriate and administered as early as possible. The aim of this manuscript is to update treatment protocols by reviewing recently published studies on the treatment of nosocomial pneumonia in the critically ill patients that require invasive respiratory support and patients with HAP from hospital wards that require invasive mechanical ventilation. An interdisciplinary group of experts, comprising specialists in anaesthesia and resuscitation and in intensive care medicine, updated the epidemiology and antimicrobial resistance and established clinical management priorities based on patients’ risk factors. Implementation of rapid diagnostic microbiological techniques available and the new antibiotics recently added to the therapeutic arsenal has been reviewed and updated. After analysis of the categories outlined, some recommendations were suggested, and an algorithm to update empirical and targeted treatment in critically ill patients has also been designed. These aspects are key to improve VAP outcomes because of the severity of patients and possible acquisition of multidrug-resistant organisms (MDROs). |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 1466-609X 1364-8535 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e83de9f24bee2623bcb6943ef4dd2cTest http://europepmc.org/articles/PMC7322703Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....32e83de9f24bee2623bcb6943ef4dd2c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1466609X 13648535 |
|---|